共 39 条
- [31] Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and former users of oral selexipag [J]. JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
- [32] Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and former users of oral selexipag [J]. Journal of Patient-Reported Outcomes, 7
- [33] Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion] [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2017, 35 (01) : 1 - 5
- [34] Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion] [J]. Journal of Bone and Mineral Metabolism, 2017, 35 : 1 - 5
- [38] Electronic multidimensional health assessment questionnaire (eMDHAQ): past, present and future of a proposed single data management system for clinical care, research, quality improvement, and monitoring of long-term outcomes [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (05) : S17 - S33